A new era of targeted therapy with antibody–drug conjugates Post author: Post published:December 16, 2024 Post category:uncategorized TBC You Might Also Like Using machine learning to predict disease progression in multiple sclerosis January 9, 2024 Boston Scientific announces agreement to acquire Bolt Medical, Inc. January 13, 2025 Research develops guidelines to address staff unprofessional behaviors at work October 31, 2023